Nephros (NEPH) Non-Current Assets (2010 - 2026)
Nephros (NEPH) recorded quarterly Non-Current Assets of $2.3 million in Q1 2026, down 4.96% quarter-over-quarter from $2.4 million in Q4 2025, and down 17.52% on a YoY basis from $2.8 million in Q1 2025.
Nephros (NEPH) Non-Current Assets (2010 - 2026) Analysis & Trends
Nephros' Non-Current Assets history runs 17 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 17.52% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $9.9 million (down 16.64% YoY), while the FY2025 annual figure was $2.4 million, down 16.96% from the prior year.
- Non-Current Assets was $2.3 million for Q1 2026 at Nephros, down from $2.4 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $3.9 million in Q1 2022 to a low of $2.2 million in Q3 2022.
- Historically, Non-Current Assets has averaged $2.9 million across 5 years, with a median of $2.7 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets plunged 47.2% in 2022, then gained 28.4% in 2024.
- A 5-year view of Non-Current Assets shows it stood at $2.7 million in 2022, then rose by 26.22% to $3.5 million in 2023, then retreated by 15.74% to $2.9 million in 2024, then declined by 16.96% to $2.4 million in 2025, then retreated by 4.96% to $2.3 million in 2026.
- The last three Non-Current Assets figures came in at $2.3 million (Q1 2026), $2.4 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 11.30 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 42.82 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 27.83 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 4.72 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 2.28 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 10.51 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.66 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.00 Bn |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 2.42 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 3.03 Mn |
| Jun 30, 2024 | 3.17 Mn |
| Mar 31, 2024 | 3.29 Mn |
| Dec 31, 2023 | 3.46 Mn |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2023 | 2.47 Mn |
| Mar 31, 2023 | 2.60 Mn |
| Dec 31, 2022 | 2.74 Mn |
| Sep 30, 2022 | 2.22 Mn |
| Jun 30, 2022 | 3.83 Mn |
| Mar 31, 2022 | 3.87 Mn |
| Dec 31, 2021 | 4.02 Mn |
| Sep 30, 2021 | 4.20 Mn |
| Jun 30, 2021 | 3.15 Mn |